Key Takeaways
- Half-year Revenue rose 23% to £95.2m (six months to 30 June 2026), with adjusted operating profit up 34% to £16.3m.
- Growth was flattered by the OKC Acquisition (£14.8m of revenue); organic revenue grew a more modest 4%.
- Footwear revenue fell 23% to £28.5m as post-2025 Demand normalised and production shifts to Vietnam.
- Management reaffirmed full-year expectations and a medium-term ambition of revenue above £230m and operating profit above £40m by FY2029.
- Statutory profit before tax rose 23% to £14.0m; the Interim Dividend was lifted 5.2% to 2.63p.
Zotefoams plc (LSE:ZTF), the London-listed specialist in cellular materials and supercritical foams, has spent several years trying to loosen its dependence on a single, cyclical end-market: athletic footwear. Its interim results for the six months to 30 June 2026, released on 5 August, offer the clearest evidence yet that the "Expanding Beyond the Core" strategy is broadening the base. Headline growth was strong, but the numbers also underline how much the picture now depends on acquisitions and on managing a difficult transition in the footwear division. This article examines what the company reported, what it means and what investors should watch next.
Latest Company Development
Zotefoams reported group revenue of £95.2m, up 23% (24% at constant currency) on the £77.4m recorded a year earlier. Adjusted operating profit rose 34% to £16.3m, lifting the adjusted Operating Margin by 130 basis points to 17.1%. The proposed headline is therefore verified, provided the profit figure is understood as adjusted operating profit; adjusted profit before tax also grew 34%, to £15.3m. On a statutory basis, growth was more measured: operating profit was £15.0m and profit before tax rose 23% to £14.0m, the difference reflecting adjusting items including acquisition and restructuring costs.
The single biggest driver of the top-line jump was OKC, the US Business acquired in November 2025, which contributed £14.8m in its first full half and was described by management as "ahead of plan". Strip out acquisitions and organic revenue growth was 4% (6% at constant currency) — respectable, but a reminder that the headline rate is not wholly organic. Group CEO Ronan Cox said the performance provided "clear evidence that Zotefoams' strategy is delivering a broader and more balanced business".
Financial and Operational Position
Profitability improved across the board. Gross Profit rose to £33.9m and the gross margin widened by around 100 basis points to 35.6%. Basic Earnings Per Share came in at 23.60p, with adjusted basic EPS up 29% to 25.70p. The board declared an interim dividend of 2.63p, a 5.2% increase.
The regional breakdown shows growth everywhere. EMEA — the largest region and home to the OKC contribution — delivered revenue of £73.6m, up 20%, at a 22.8% operating margin. North America grew 29% to £18.7m, while Asia, from a small base, more than doubled to £2.9m as T-FIT thermal insulation gained traction in India and China.
The counterweight sits in the footwear franchise, historically the engine of Zotefoams' high-performance products and its exposure to major sportswear brands. Footwear revenue fell 23% to £28.5m, from £37.0m, as exceptional 2025 demand normalised and the business transitions from supplying sheet material to 3D preforms while Manufacturing relocates towards Vietnam. Transport and smart technologies, by contrast, showed "continued momentum", including aerospace and space wins.
Balance-sheet gearing has risen following the acquisition. Net Debt on a covenant basis stood at £39.1m, up from £21.1m, taking Leverage to 0.98x from 0.68x. Liquidity headroom was £50.2m. That is still comfortably within facilities, but it leaves less slack than a year ago.
What Could Drive the Shares Next
Several company-specific catalysts lie ahead. The new Vietnam Facility is scheduled to begin trial production in October 2026, positioning Zotefoams closer to where footwear manufacturing is migrating. A restructuring of the UK Croydon operations is expected to deliver around £4m of annualised savings, albeit subject to consultation affecting more than 100 employees. A Footwear Innovation Centre in South Korea is now operational, and the diversifying revenue streams — ReZorce recyclable barrier packaging and T-FIT insulation — offer optionality beyond the core polyolefin (Azote) block-foam business.
The clearest signposted milestone is the medium-term ambition management reiterated: revenue above £230m and operating profit above £40m by FY2029. That is a company target rather than a forecast, and delivering it would require the newer platforms and acquisitions to compound while footwear recovers. For the current year, the group said it remains confident of delivering results "in line with market expectations".
Risks Investors Should Watch
The most immediate risk is footwear. Management expects volumes to be "lower through the second half of 2026 and into 2027", with recovery not anticipated until 2028. Because footwear has historically carried attractive margins, a prolonged trough could weigh on group profitability even as other divisions grow.
Second, the transition itself carries execution risk. Running production across the UK and Vietnam simultaneously will, in the CEO's words, "create some temporary inefficiency" — a candid acknowledgement that margins could be choppy during commissioning.
Third, the quality of the reported growth deserves scrutiny. With organic growth at 4% and much of the headline uplift acquisition-driven, integration of OKC and the durability of its early outperformance matter. Higher net debt and leverage of nearly 1.0x also reduce financial flexibility, and the Croydon restructuring, while sensible on cost, invokes consultation and one-off charges.
Finally, Zotefoams remains exposed to broad macroeconomic uncertainty, currency movements and the capital-intensity of expanding manufacturing across multiple geographies.
Outlook
Management framed 2026 as a transitional year and pointed repeatedly to "materially stronger value creation from 2028 onwards", once footwear stabilises and the Vietnam and Diversification investments mature. In the near term, the reaffirmed full-year guidance and a strong first half provide a degree of visibility, but the second-half comparison against a still-elevated footwear base looks demanding. Investors should treat the 2028-plus narrative as an ambition to be tested rather than a delivered result.
Final Take
Zotefoams' interim numbers are genuinely strong at the headline level and validate the strategic logic of building a broader business less beholden to a single customer segment. The 23% revenue rise and 34% jump in adjusted operating profit are real and verified. Yet the composition matters: acquisitions did the heavy lifting, footwear is contracting sharply, and gearing has stepped up. The Investment case now hinges on whether the newer platforms and the Vietnam transition can carry the group through a soft footwear patch and toward its 2029 ambitions. The first half suggests the strategy is working; the next 18 months will show how resilient it really is.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...